Clinical Trial Update: Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's Disease [Phase 3]

View source ↗

Summary

Phase 3 trial comparing continuous subcutaneous infusion of ABBV-951 with oral carbidopa/levodopa in adults with advanced Parkinson's disease has completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• ABBV-951

Snippet

Sponsor: AbbVie | Conditions: Parkinson's Disease (PD) | Phase 3 | Status: COMPLETED | Results posted: 2022-11-18